1
|
Lipska I, Di Bidino R, Niewada M, Nemeth B, Bochenek T, Kukla M, Więckowska B, Sobczak A, Iłowiecka K, Zemplenyi A, Martelli N, Martin T, Filiniuk O, Kosyachenko K, Sucu R, Piniazhko O, Zaliska O, Avdeyev A, Shanazarov N, von Pinoci M, Hren R. Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus. Healthcare (Basel) 2024; 12:889. [PMID: 38727447 PMCID: PMC11083158 DOI: 10.3390/healthcare12090889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 04/17/2024] [Accepted: 04/23/2024] [Indexed: 05/13/2024] Open
Abstract
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.
Collapse
Affiliation(s)
- Iga Lipska
- Health Policy Institute, 00-819 Warsaw, Poland; (I.L.); (A.S.); (K.I.)
- Medical Department, Academy of Applied Medical and Social Sciences, 82-300 Elbląg, Poland
- Hospital-Based Health Technology Assessment Interest Group, Health Technology Assessment International, Edmonton, AB T6H 5P9, Canada; (M.K.); (R.S.)
| | - Rossella Di Bidino
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy;
- Health Graduate School of Health Economics and Management (ALTEMS), Università Cattolica Del Sacro Cuore, 00168 Rome, Italy
| | - Maciej Niewada
- Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-091 Warsaw, Poland;
| | - Bertalan Nemeth
- Syreon Research Institute, 1142 Budapest, Hungary; (B.N.); (A.Z.)
| | - Tomasz Bochenek
- Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-126 Krakow, Poland;
| | - Monika Kukla
- Hospital-Based Health Technology Assessment Interest Group, Health Technology Assessment International, Edmonton, AB T6H 5P9, Canada; (M.K.); (R.S.)
| | - Barbara Więckowska
- Social Insurance Department, Warsaw School of Economics, 02-554 Warsaw, Poland;
| | - Alicja Sobczak
- Health Policy Institute, 00-819 Warsaw, Poland; (I.L.); (A.S.); (K.I.)
| | | | - Antal Zemplenyi
- Syreon Research Institute, 1142 Budapest, Hungary; (B.N.); (A.Z.)
- Center for Health Technology Assessment and Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary
| | - Nicolas Martelli
- Pharmacy Department, Georges Pompidou European Hospital, 75015 Paris, France; (N.M.); (T.M.)
- Faculty of Pharmacy, Université Paris-Saclay, GRADES, 91190 Orsay, France
| | - Tess Martin
- Pharmacy Department, Georges Pompidou European Hospital, 75015 Paris, France; (N.M.); (T.M.)
- Faculty of Pharmacy, Université Paris-Saclay, GRADES, 91190 Orsay, France
| | - Olena Filiniuk
- Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity, Management Sciences for Health, 02000 Kyiv, Ukraine;
| | - Kostyantyn Kosyachenko
- Department of Management and Economy of Pharmacy, Bogomolets National Medical University, 01601 Kyiv, Ukraine;
| | - Rabia Sucu
- Hospital-Based Health Technology Assessment Interest Group, Health Technology Assessment International, Edmonton, AB T6H 5P9, Canada; (M.K.); (R.S.)
| | - Oresta Piniazhko
- Department of Health Technology Assessment, State Expert Center, Ministry of Health of Ukraine, 01021 Kyiv, Ukraine;
- Department of Management and Economy of Pharmacy, Medicine Technology and Pharmacoeconomics, Faculty of Postgraduate Education, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine;
| | - Olha Zaliska
- Department of Management and Economy of Pharmacy, Medicine Technology and Pharmacoeconomics, Faculty of Postgraduate Education, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine;
| | - Andrey Avdeyev
- Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan; (A.A.); (N.S.)
| | - Nasrulla Shanazarov
- Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan; (A.A.); (N.S.)
| | - Marina von Pinoci
- Care Quality Division, Hôpitaux Universitaires de Genève, 1211 Geneva, Switzerland;
| | - Rok Hren
- Syreon Research Institute, 1142 Budapest, Hungary; (B.N.); (A.Z.)
- Institute of Mathematics, Physics, and Mechanics, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia
| |
Collapse
|
2
|
Martin T, Guercio A, Besseau H, Huot L, Guerre P, Atfeh J, Piazza L, Pineau J, Sabatier B, Borget I, Martelli N. Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France. Int J Technol Assess Health Care 2023; 39:e58. [PMID: 37732461 DOI: 10.1017/s0266462323000521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/22/2023]
Abstract
OBJECTIVES To better understand the process of hospital acquisition of innovative medical devices (MDs) and the hospital-based health technology assessment (HB-HTA) pathways in France, an in-depth study based on a quantitative approach is needed. The aim of the present study was to assess through a national survey how HB-HTA is currently implemented in French hospitals and to identify its level of formalization. METHODS A quantitative online survey was conducted among hospitals performing HB-HTA in France, with a focus on the acquisition of innovative MDs for individual use. The survey, conducted between March and June 2022, was developed by a scientific board composed of members of the French-speaking Society for HB-HTA. RESULTS Sixty-seven out of 131 surveyed hospitals with HB-HTA activities responded, including 29 university hospitals, 24 nonprofit private hospitals, and 14 local hospitals. Sixty-one respondents (91 percent) reported the existence of a process dedicated to evaluating innovative MDs; of these, 16 declared that their hospitals had a formalized unit with HB-HTA activity. These units were more frequently found in larger hospitals with more than 500 inpatient beds (n = 16, p = 0.0160) and in university hospitals (n = 12, p = 0.0158). No hospital reported any collaboration with HAS, the French national HTA agency. CONCLUSION A diverse range of HB-HTA organizations with different structural levels exist in France for MD procurement linked to the category of hospitals. The study highlights the need for recognition of HB-HTA activity at the regulatory level in France and for direct collaboration between HTA activities performed at local and national levels.
Collapse
Affiliation(s)
- Tess Martin
- Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
- Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
| | - Alessandra Guercio
- Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
| | - Hélène Besseau
- Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
| | - Laure Huot
- Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France
- Université Lyon 1, INSERM U1290 Research on Healthcare Performance RESHAPE, Lyon, France
| | - Pascale Guerre
- Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France
- Lyon University, Univ. Claude Bernard Lyon 1, P2S UR4129, Lyon, France
| | - Jamal Atfeh
- Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France
| | - Laurent Piazza
- Health Economics Unit, Clinical Research Department, Bordeaux University Hospital, Talence, France
| | - Judith Pineau
- Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
| | - Brigitte Sabatier
- Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
| | - Isabelle Borget
- Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France
- Inserm, Université Paris-Saclay, CESP U1018, Oncostat, Certified Ligue Contre le Cancer, Villejuif, France
| | - Nicolas Martelli
- Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
- Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
| |
Collapse
|
3
|
Furman M, Gałązka-Sobotka M, Marciniak D, Kowalska-Bobko I. Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:11235. [PMID: 36141507 PMCID: PMC9517551 DOI: 10.3390/ijerph191811235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Revised: 08/29/2022] [Accepted: 08/31/2022] [Indexed: 06/16/2023]
Abstract
The Health Technology Assessment is based on the evaluation of the characteristics and effects of health technologies to properly spend resources in healthcare. For the needs of hospitals, a special HTA department, Hospital-Based Health Technology Assessment (HB-HTA), has been established. The objective of the article is to assess the possibility of implementing a functional model with the coordinating role of Health Departments of the Voivodeship Offices with the support of the National Health Fund and the HTA Agency in Poland. Ten semi-structured interviews were conducted with representatives from eight Voivodeship Offices. The interviews consisted of nine questions related to the possibility of introducing a functional model with the participation of the Voivodeship Office. The material was divided into seven codes relating to the questions included in the topic guide. From the perspective of Voivodeship Offices, HB-HTA could contribute to the improvement of the methodology used in the Evaluation Instrument of Investment Motions in Health. The lack of personnel in the Voivodeship Offices was identified as one of the greatest barriers to the implementation of HB-HTA. These public administration units should not be involved in the hospital health technology assessment process.
Collapse
Affiliation(s)
- Maciej Furman
- Department of Health Policy and Management, Faculty of Health Sciences, Institute of Public Health, Jagiellonian University Medical College, 31-066 Cracow, Poland
| | | | - Damian Marciniak
- Institute of Healthcare Management, Lazarski University, 02-662 Warsaw, Poland
| | - Iwona Kowalska-Bobko
- Department of Health Policy and Management, Faculty of Health Sciences, Institute of Public Health, Jagiellonian University Medical College, 31-066 Cracow, Poland
- Institute of Healthcare Management, Lazarski University, 02-662 Warsaw, Poland
| |
Collapse
|
4
|
Using the Dynamic SWOT Analysis to Assess Options for Implementing the HB-HTA Model. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19127281. [PMID: 35742532 PMCID: PMC9224318 DOI: 10.3390/ijerph19127281] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Revised: 06/05/2022] [Accepted: 06/11/2022] [Indexed: 02/04/2023]
Abstract
This paper is aimed at exploring the role of the HB-HTA ecosystem as an important pathway for popularizing the implementation of innovations in healthcare organizations. The scientific debate has largely been focused on the rising importance of HB-HTA and the principles guiding the process. Solutions implemented by individual countries differ, which may be rooted in historical, cultural, and institutional differences. Our understanding of the impact of individual countries’ healthcare systems on HB-HTA solutions and infrastructure still lacks a basis in interpretative studies. A conceptual framework is proposed to assess the aptness of the HB-HTA model designed for hospitals operating in a country or region, focused on the concepts of adaptiveness and responsiveness to features of the healthcare system present there. A tool is proposed for investigating factors that are likely to assist the successful implementation of the HB-HTA ecosystem. A dynamic SWOT analysis on the case of the HB-HTA model designed for Poland provides interesting insights into the building of the conceptual framework. The results of this study help explain how to create an HB-HTA model that is best adapted to the regional or national healthcare system, including potential risks and opportunities.
Collapse
|
5
|
Gałązka-Sobotka M, Frączkiewicz-Wronka A, Kowalska-Bobko I, Kelm H, Szymaniec-Mlicka K. HB-HTA as an implementation problem in Polish health policy. PLoS One 2021; 16:e0257451. [PMID: 34559806 PMCID: PMC8462719 DOI: 10.1371/journal.pone.0257451] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2021] [Accepted: 09/02/2021] [Indexed: 11/21/2022] Open
Abstract
Hospital Based Health Technology Assessment (HB-HTA) is a new policy implemented in Poland to allow for a more practical and contextualized assessment related to the use of specific medical procedures, devices, or equipment. It requires changes in governance relating to the healthcare sector. One of the forms of governance improvement is to involve society in the process of creating public services. This can be implemented, e.g., by applying the pragmatic model of public responsiveness. The aim of this research was to identify and analyze forces which will shape a dynamic process in determining the implementation of HB-HTA. The results obtained in the Gioia analysis led to the identification of the main forces driving and restraining the implementation of HB-HTA. The grouping and interpretation allowed for the twelve most important dimensions to be distinguished, which were recognized as conceptual categories necessary to build theories that describe the studied phenomenon. This study contributes to the development of the idea of responsiveness in public management theory and in health care services, and ultimately helps to better enable the adjustment of health services to the dynamically changing needs of Polish society.
Collapse
Affiliation(s)
| | | | - Iwona Kowalska-Bobko
- Faculty of Health Science, Institute of Public Health, Medical College, Jagiellonian Univeristy, Krakow, Poland
| | - Hanna Kelm
- Department of Public Management, University of Economics in Katowice, Katowice, Poland
| | | |
Collapse
|